Paul L. Canner

7.4k total citations · 1 hit paper
43 papers, 2.8k citations indexed

About

Paul L. Canner is a scholar working on Statistics and Probability, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul L. Canner has authored 43 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Statistics and Probability, 11 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul L. Canner's work include Statistical Methods in Clinical Trials (14 papers), Lipoproteins and Cardiovascular Health (7 papers) and Advanced Causal Inference Techniques (6 papers). Paul L. Canner is often cited by papers focused on Statistical Methods in Clinical Trials (14 papers), Lipoproteins and Cardiovascular Health (7 papers) and Advanced Causal Inference Techniques (6 papers). Paul L. Canner collaborates with scholars based in United States, Canada and Vietnam. Paul L. Canner's co-authors include Kenneth G. Berge, Jeremiah Stamler, Ronald J. Prineas, Lawrence M. Friedman, Nanette K. Wenger, William T. Friedewald, Mark E. McGovern, Curt D. Furberg, Michael L. Terrin and Sandra Forman and has published in prestigious journals such as Circulation, Journal of the American Statistical Association and Journal of the American College of Cardiology.

In The Last Decade

Paul L. Canner

43 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin

1986 1.3k citations Paul L. Canner, Kenneth G. Berge et al. Journal of the American College of Cardiology profile →

Peers

Paul L. Canner

SURGE

EDM

CCM

Markus Abt Switzerland

Marjatta Mälkönen Finland

Michel Komajda France

Virginia Fitzpatrick United States

Sarah Parish United Kingdom

Jacques LeLorier Canada

Margaret J. Thomason United Kingdom

James H. Revkin United States

A. Tonkin Australia

Paul Drury United Kingdom

Markus Abt Switzerland

Paul L. Canner

1.5k ×1.0

SURGE

1.1k ×1.0

EDM

669 ×0.8

CCM

458 ×1.3

188 ×0.6

Citations per year, relative to Paul L. Canner Paul L. Canner (= 1×) peers Markus Abt

Countries citing papers authored by Paul L. Canner

Since Specialization

Citations

This map shows the geographic impact of Paul L. Canner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Canner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Canner more than expected).

Fields of papers citing papers by Paul L. Canner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Canner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Canner. The network helps show where Paul L. Canner may publish in the future.

Co-authorship network of co-authors of Paul L. Canner

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Canner. A scholar is included among the top collaborators of Paul L. Canner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Canner. Paul L. Canner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maccubbin, Darbie, et al.. (2013). Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. International Journal of Clinical Practice. 67(4). 297–302. 33 indexed citations

Canner, Paul L., Curt D. Furberg, Michael L. Terrin, & Mark E. McGovern. (2005). Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project). The American Journal of Cardiology. 95(2). 254–257. 161 indexed citations

Canner, Paul L., Curt D. Furberg, & Mark E. McGovern. (2005). Benefits of Niacin in Patients With Versus Without the Metabolic Syndrome and Healed Myocardial Infarction (from the Coronary Drug Project). The American Journal of Cardiology. 97(4). 477–479. 94 indexed citations

Canner, Paul L., Curt D. Furberg, Michael L. Terrin, & Mark E. McGovern. (2003). Niacin decreases myocardial infarction and total mortality in patients with metabolic syndrome: Results from the coronary drug project. Journal of the American College of Cardiology. 41(6). 291–291. 19 indexed citations

White, Carl W., Lucien Campeau, Paul L. Canner, et al.. (2001). Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials∗∗The list of the Post CABG Investigators appears in another publication.. The American Journal of Cardiology. 87(1). 40–43. 4 indexed citations

Canner, Paul L., Bruce Thompson, Genell L. Knatterud, et al.. (1997). An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial. Controlled Clinical Trials. 18(4). 318–327. 5 indexed citations

Berge, Kenneth G. & Paul L. Canner. (1991). Coronary drug project: experience with niacin. European Journal of Clinical Pharmacology. 40(S1). S49–S51. 54 indexed citations

Canner, Paul L.. (1991). Covariate adjustment of treatment effects in clinical trials. Controlled Clinical Trials. 12(3). 359–366. 39 indexed citations

Canner, Paul L., Nemat O. Borhani, Albert Oberman, et al.. (1991). The Hypertension Prevention Trial: Assessment of the Quality of Blood Pressure Measurements. American Journal of Epidemiology. 134(4). 379–392. 61 indexed citations

10.

Berge, Kenneth G. & Paul L. Canner. (1991). Coronary drug project: Experience with niacin. European Journal of Clinical Pharmacology. 40(1). S49–S51. 32 indexed citations

11.

Canner, Paul L., et al.. (1989). Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials. 10(3). 84S–101S. 25 indexed citations

12.

Canner, Paul L., Kenneth G. Berge, Nanette K. Wenger, et al.. (1986). Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin. Journal of the American College of Cardiology. 8(6). 1245–1255. 1336 indexed citations breakdown →

13.

Canner, Paul L.. (1985). Mortality in Coronary Drug Project Patients During a Nine-Year Posttreatment Period. Journal of Cardiopulmonary Rehabilitation. 5(6). 291–291. 7 indexed citations

14.

Rand, Lawrence I., Gérald J. Prud’homme, Fred Ederer, & Paul L. Canner. (1985). Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10.. PubMed. 26(7). 983–91. 59 indexed citations

15.

Goldstein, Sidney, Lawrence M. Friedman, Richard G. Hutchinson, et al.. (1984). Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients. Journal of the American College of Cardiology. 3(5). 1111–1117. 49 indexed citations

16.

Canner, Paul L.. (1983). Monitoring of the data for evidence of adverse or beneficial treatment effects. Controlled Clinical Trials. 4(4). 467–483. 24 indexed citations

17.

Knatterud, Genell L., Sandra Forman, & Paul L. Canner. (1983). Design of data forms. Controlled Clinical Trials. 4(4). 429–440. 6 indexed citations

18.

Canner, Paul L.. (1983). Brief description of the coronary drug project and other studies. Controlled Clinical Trials. 4(4). 273–280. 4 indexed citations

19.

Canner, Paul L.. (1975). A Simulation Study of One- and Two-Sample Kolmogorov-Smirnov Statistics with a Particular Weight Function. Journal of the American Statistical Association. 70(349). 209–211. 29 indexed citations

20.

Canner, Paul L.. (1970). Selecting One of Two Treatments when the Responses are Dichotomous. Journal of the American Statistical Association. 65(329). 293–293. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact